Celgene European Investment Co LLC

CIK 1577650 · last filed 2019-11-14

Celgene European Investment Co LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing shows the insider bought $50.0M of AGIO on Nov 14, 2019. Across all open-market trades the lifetime net is +$95.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $170.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$170.54M

Companies

2

Total Filings

3

Lifetime Open-Market Net

$95.21M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AGIO 10%+ Owner 5,788,750 $29.46 $170.54M $75.32M 2 2019-11-14
Epizyme, Inc. (EPZM) Delisted 10%+ Owner 3,674,640 $1.47 $5.40M $19.89M 1 2014-02-11

Recent Filings

3 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-11-14 AGIO Buy (P) +1,612,900 $50.00M EDGAR
2014-12-17 AGIO Buy (P) +228,645 $25.32M EDGAR
2014-02-11 Epizyme, Inc. (EPZM) Delisted Buy (P) +680,000 $19.89M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.